MXPA04002473A - Inhibition of exoproteins using isoprenoids. - Google Patents

Inhibition of exoproteins using isoprenoids.

Info

Publication number
MXPA04002473A
MXPA04002473A MXPA04002473A MXPA04002473A MXPA04002473A MX PA04002473 A MXPA04002473 A MX PA04002473A MX PA04002473 A MXPA04002473 A MX PA04002473A MX PA04002473 A MXPA04002473 A MX PA04002473A MX PA04002473 A MXPA04002473 A MX PA04002473A
Authority
MX
Mexico
Prior art keywords
exoproteins
isoprenoids
inhibition
exotoxins
production
Prior art date
Application number
MXPA04002473A
Other languages
Spanish (es)
Inventor
Ellen Syverson Rae
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/969,198 external-priority patent/US6596290B2/en
Priority claimed from US09/968,769 external-priority patent/US6534548B1/en
Priority claimed from US09/969,199 external-priority patent/US8084046B2/en
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of MXPA04002473A publication Critical patent/MXPA04002473A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45Mixtures of two or more drugs, e.g. synergistic mixtures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Absorbent articles, such as catamenial tampons, are disclosed. The absorbent articles include an effective amount of an isoprenoid inhibitory compound to substantially inhibit the production of exotoxins by Gram positive bacteria. The isoprenoid inhibitory compounds of the present invention include terpenes and terpenoids which substantially reduce the production of exotoxins by Gram positive bacteria.
MXPA04002473A 2001-10-02 2002-09-09 Inhibition of exoproteins using isoprenoids. MXPA04002473A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/969,198 US6596290B2 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in non-absorbent articles using isoprenoid compositions
US09/968,769 US6534548B1 (en) 2001-10-02 2001-10-02 Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria
US09/969,199 US8084046B2 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in absorbent articles using isoprenoids
PCT/US2002/028758 WO2003028777A1 (en) 2001-10-02 2002-09-09 Inhibition of exoproteins using isoprenoids

Publications (1)

Publication Number Publication Date
MXPA04002473A true MXPA04002473A (en) 2004-05-31

Family

ID=27420758

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002473A MXPA04002473A (en) 2001-10-02 2002-09-09 Inhibition of exoproteins using isoprenoids.

Country Status (8)

Country Link
EP (1) EP1432458A1 (en)
JP (1) JP2005528928A (en)
KR (1) KR20040044949A (en)
AR (1) AR036718A1 (en)
BR (1) BR0212675A (en)
CA (1) CA2461197A1 (en)
MX (1) MXPA04002473A (en)
WO (1) WO2003028777A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224034A1 (en) * 2002-05-31 2003-12-04 Koenig David W. Personal care article and method for inhibiting attachment of yeast to skin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0521143B1 (en) * 1991-01-17 1997-04-02 Water-Jel Technologies, Inc. Burn dressing with tea tree oil
AU6253996A (en) * 1995-06-07 1996-12-30 Kimberly-Clark Worldwide, Inc. Inhibition of exoprotein in absorbent article
DE29521478U1 (en) * 1995-12-05 1997-07-10 Turetschek-Fenke, Adelheid, 80995 München Ergonomic sanitary napkin with high absorbency, antibacterial effect and strong odor control
FR2747310B1 (en) * 1996-04-15 1998-06-05 Inbrand France IMPROVED HYGIENIC PROTECTION COMPRISING AN ANTISEPTIC
GB9612595D0 (en) * 1996-06-15 1996-08-21 Smithkline Beecham Plc Composition
KR100563881B1 (en) * 1998-05-29 2006-03-28 킴벌리-클라크 월드와이드, 인크. Enhanced Odor Absorption by Natural and Synthetic Polymers

Also Published As

Publication number Publication date
EP1432458A1 (en) 2004-06-30
BR0212675A (en) 2005-04-12
KR20040044949A (en) 2004-05-31
WO2003028777A1 (en) 2003-04-10
JP2005528928A (en) 2005-09-29
CA2461197A1 (en) 2003-04-10
AR036718A1 (en) 2004-09-29

Similar Documents

Publication Publication Date Title
IL153406A0 (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
AU2002239344A1 (en) Pyrazolopyridines
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA02012271A (en) Novel compounds possessing antibacterial, antifungal or antitumor activity.
AU5636298A (en) Stretchable absorbent structure
WO2004014893A3 (en) Antimicrobial aza-bicyclic derivates, their compositions and uses
WO2004035569A3 (en) Novel compounds with antibacterial activity
WO2003095455A3 (en) Substituted pyrazolopyrimidines
DE60112330D1 (en) Pyrazolopyridinderivate
HK1068274A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
EP1053989A3 (en) Hydroxydiphenyl ether compounds
WO2002010152A3 (en) Novel indole derivatives and their use as medicaments
UA74430C2 (en) PHENYLHETEROCYCLIC ETHERS DERIVATIVES AS serotonin re-uptake inhibitors
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
WO2004075846A3 (en) Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
AU2001289714A1 (en) Benzofuran derivatives and their use as antibacterial agents
MXPA04002473A (en) Inhibition of exoproteins using isoprenoids.
IL140768A0 (en) Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
WO2006055663A3 (en) The use of novel antibacterial compounds
MXPA04004090A (en) Substituted 1h-quinolin-2-one compounds.
WO2004060878A3 (en) Inhibitors of phosphatases
MXPA03005374A (en) Antitumoral carbazoles.
AU2002214197A1 (en) Macrolides
WO2002048092A3 (en) Compounds for altering mitochondrial function and cellular responses
MXPA02011405A (en) Methods for inhibiting the production of tsst-1.